Wednesday, July 8, 2026

biotech · Amyotrophic Lateral Sclerosis (ALS) · Amyotrophic Lateral Sclerosis · BCLI

BRAINSTORM CELL THERAPEUTICS

BRAINSTORM CELL THERAPEUTICS trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

NEW YORK, NY, USA HQ
2004 Founded
30 Employees
Public company Type
BCLI · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, USA
Founded
2004
Employees
30
Programs
5
Drugs
5
Patents
8
Intelligence · Clinical Trials

BRAINSTORM CELL THERAPEUTICS clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to BRAINSTORM CELL THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

BRAINSTORM CELL THERAPEUTICS trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for BRAINSTORM CELL THERAPEUTICS.

  1. MSC-NTF-002-HMO-CTIL — Phase 2

    Clinical update
  2. MSC-NTF cells transplantation (IM) — Phase 2

    Clinical update
  3. NurOwn (MSC-NTF cells) — Phase 2

    Clinical update
  4. NurOwn® (MSC-NTF cells) — Phase 3

    Clinical update
  5. Debamestrocel - MSC-NTF (NurOwn) — Phase 3

    Clinical update

Trial registry

6 studies